메뉴 건너뛰기




Volumn 36, Issue , 2014, Pages 91-101

The structural basis for mTOR function

Author keywords

4E BP1; MTOR; PI3K; PIKK; Rapamycin; S6K1

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; RAPAMYCIN; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

EID: 84912072020     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2014.09.024     Document Type: Review
Times cited : (53)

References (66)
  • 1
    • 84890149646 scopus 로고    scopus 로고
    • Where is mTOR and what is it doing there?
    • Betz C., Hall M.N. Where is mTOR and what is it doing there?. J Cell Biol 2013, 203:563-574.
    • (2013) J Cell Biol , vol.203 , pp. 563-574
    • Betz, C.1    Hall, M.N.2
  • 2
    • 0037178781 scopus 로고    scopus 로고
    • Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action
    • Hara K., Maruki Y., Long X., Yoshino K., Oshiro N., Hidayat S., et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 2002, 110:177-189.
    • (2002) Cell , vol.110 , pp. 177-189
    • Hara, K.1    Maruki, Y.2    Long, X.3    Yoshino, K.4    Oshiro, N.5    Hidayat, S.6
  • 3
    • 0036753494 scopus 로고    scopus 로고
    • Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control
    • Loewith R., Jacinto E., Wullschleger S., Lorberg A., Crespo J.L., Bonenfant D., et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell 2002, 10:457-468.
    • (2002) Mol Cell , vol.10 , pp. 457-468
    • Loewith, R.1    Jacinto, E.2    Wullschleger, S.3    Lorberg, A.4    Crespo, J.L.5    Bonenfant, D.6
  • 4
    • 0037178786 scopus 로고    scopus 로고
    • MTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery
    • Kim D.H., Sarbassov D.D., Ali S.M., King J.E., Latek R.R., Erdjument-Bromage H., et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002, 110:163-175.
    • (2002) Cell , vol.110 , pp. 163-175
    • Kim, D.H.1    Sarbassov, D.D.2    Ali, S.M.3    King, J.E.4    Latek, R.R.5    Erdjument-Bromage, H.6
  • 5
    • 3342895823 scopus 로고    scopus 로고
    • Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
    • Sarbassov D.D., Ali S.M., Kim D.H., Guertin D.A., Latek R.R., Erdjument-Bromage H., et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 2004, 14:1296-1302.
    • (2004) Curr Biol , vol.14 , pp. 1296-1302
    • Sarbassov, D.D.1    Ali, S.M.2    Kim, D.H.3    Guertin, D.A.4    Latek, R.R.5    Erdjument-Bromage, H.6
  • 6
    • 0037732600 scopus 로고    scopus 로고
    • LST8 negatively regulates amino acid biosynthesis as a component of the TOR pathway
    • Chen E.J., Kaiser C.A. LST8 negatively regulates amino acid biosynthesis as a component of the TOR pathway. J Cell Biol 2003, 161:333-347.
    • (2003) J Cell Biol , vol.161 , pp. 333-347
    • Chen, E.J.1    Kaiser, C.A.2
  • 7
    • 0037623417 scopus 로고    scopus 로고
    • GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR
    • Kim D.H., Sarbassov D.D., Ali S.M., Latek R.R., Guntur K.V., Erdjument-Bromage H., et al. GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol Cell 2003, 11:895-904.
    • (2003) Mol Cell , vol.11 , pp. 895-904
    • Kim, D.H.1    Sarbassov, D.D.2    Ali, S.M.3    Latek, R.R.4    Guntur, K.V.5    Erdjument-Bromage, H.6
  • 8
    • 67349241955 scopus 로고    scopus 로고
    • DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival
    • Peterson T.R., Laplante M., Thoreen C.C., Sancak Y., Kang S.A., Kuehl W.M., et al. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 2009, 137:873-886.
    • (2009) Cell , vol.137 , pp. 873-886
    • Peterson, T.R.1    Laplante, M.2    Thoreen, C.C.3    Sancak, Y.4    Kang, S.A.5    Kuehl, W.M.6
  • 9
    • 83455177213 scopus 로고    scopus 로고
    • Target of rapamycin (TOR) in nutrient signaling and growth control
    • Loewith R., Hall M.N. Target of rapamycin (TOR) in nutrient signaling and growth control. Genetics 2011, 189:1177-1201.
    • (2011) Genetics , vol.189 , pp. 1177-1201
    • Loewith, R.1    Hall, M.N.2
  • 10
    • 78650510609 scopus 로고    scopus 로고
    • MTOR: from growth signal integration to cancer, diabetes and ageing
    • Zoncu R., Efeyan A., Sabatini D.M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011, 12:21-35.
    • (2011) Nat Rev Mol Cell Biol , vol.12 , pp. 21-35
    • Zoncu, R.1    Efeyan, A.2    Sabatini, D.M.3
  • 12
    • 77953091045 scopus 로고    scopus 로고
    • Structure of the human mTOR complex I and its implications for rapamycin inhibition
    • Yip C.K., Murata K., Walz T., Sabatini D.M., Kang S.A. Structure of the human mTOR complex I and its implications for rapamycin inhibition. Mol Cell 2010, 38:768-774.
    • (2010) Mol Cell , vol.38 , pp. 768-774
    • Yip, C.K.1    Murata, K.2    Walz, T.3    Sabatini, D.M.4    Kang, S.A.5
  • 14
    • 34547099855 scopus 로고    scopus 로고
    • PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding
    • Wang L., Harris T.E., Roth R.A., Lawrence J.C. PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. J Biol Chem 2007, 282:20036-20044.
    • (2007) J Biol Chem , vol.282 , pp. 20036-20044
    • Wang, L.1    Harris, T.E.2    Roth, R.A.3    Lawrence, J.C.4
  • 15
    • 43249124698 scopus 로고    scopus 로고
    • PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis
    • Thedieck K., Polak P., Kim M.L., Molle K.D., Cohen A., Jenö P., et al. PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis. PLoS ONE 2007, 2:e1217.
    • (2007) PLoS ONE , vol.2 , pp. e1217
    • Thedieck, K.1    Polak, P.2    Kim, M.L.3    Molle, K.D.4    Cohen, A.5    Jenö, P.6
  • 16
    • 84880709668 scopus 로고    scopus 로고
    • MTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycin
    • Kang S.A., Pacold M.E., Cervantes C.L., Lim D., Lou H.J., Ottina K.A., et al. mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycin. Science 2013, 341:1236566.
    • (2013) Science , vol.341 , pp. 1236566
    • Kang, S.A.1    Pacold, M.E.2    Cervantes, C.L.3    Lim, D.4    Lou, H.J.5    Ottina, K.A.6
  • 18
    • 0037462453 scopus 로고    scopus 로고
    • The ATRs, ATMs, and TORs are giant HEAT repeat proteins
    • Perry J., Kleckner N. The ATRs, ATMs, and TORs are giant HEAT repeat proteins. Cell 2003, 112:151-155.
    • (2003) Cell , vol.112 , pp. 151-155
    • Perry, J.1    Kleckner, N.2
  • 20
    • 73849140503 scopus 로고    scopus 로고
    • Crystal structure of DNA-PKcs reveals a large open-ring cradle comprised of HEAT repeats
    • Sibanda B.L., Chirgadze D.Y., Blundell T.L. Crystal structure of DNA-PKcs reveals a large open-ring cradle comprised of HEAT repeats. Nature 2010, 463:118-121.
    • (2010) Nature , vol.463 , pp. 118-121
    • Sibanda, B.L.1    Chirgadze, D.Y.2    Blundell, T.L.3
  • 21
    • 84905705220 scopus 로고    scopus 로고
    • Structures of SMG1-UPFs complexes: SMG1 contributes to regulate UPF2-dependent activation of UPF1 in NMD
    • Melero R., Uchiyama A., Castano R., Kataoka N., Kurosawa H., Ohno S., et al. Structures of SMG1-UPFs complexes: SMG1 contributes to regulate UPF2-dependent activation of UPF1 in NMD. Structure 2014, 22:1105-1119.
    • (2014) Structure , vol.22 , pp. 1105-1119
    • Melero, R.1    Uchiyama, A.2    Castano, R.3    Kataoka, N.4    Kurosawa, H.5    Ohno, S.6
  • 23
    • 0037117409 scopus 로고    scopus 로고
    • Identification of a conserved motif required for mTOR signaling
    • Schalm S.S., Blenis J. Identification of a conserved motif required for mTOR signaling. Curr Biol 2002, 12:632-639.
    • (2002) Curr Biol , vol.12 , pp. 632-639
    • Schalm, S.S.1    Blenis, J.2
  • 24
    • 0037718389 scopus 로고    scopus 로고
    • TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function
    • Schalm S.S., Fingar D.C., Sabatini D.M., Blenis J. TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function. Curr Biol 2003, 13:797-806.
    • (2003) Curr Biol , vol.13 , pp. 797-806
    • Schalm, S.S.1    Fingar, D.C.2    Sabatini, D.M.3    Blenis, J.4
  • 25
    • 84880877011 scopus 로고    scopus 로고
    • Crystal structures of S6K1 provide insights into the regulation mechanism of S6K1 by the hydrophobic motif
    • Wang J., Zhong C., Wang F., Qu F., Ding J. Crystal structures of S6K1 provide insights into the regulation mechanism of S6K1 by the hydrophobic motif. Biochem J 2013, 454:39-47.
    • (2013) Biochem J , vol.454 , pp. 39-47
    • Wang, J.1    Zhong, C.2    Wang, F.3    Qu, F.4    Ding, J.5
  • 26
    • 0031821410 scopus 로고    scopus 로고
    • The interaction of eIF4E with 4E-BP1 is an induced fit to a completely disordered protein
    • Fletcher C.M., Wagner G. The interaction of eIF4E with 4E-BP1 is an induced fit to a completely disordered protein. Protein Sci 1998, 7:1639-1642.
    • (1998) Protein Sci , vol.7 , pp. 1639-1642
    • Fletcher, C.M.1    Wagner, G.2
  • 27
    • 64849101452 scopus 로고    scopus 로고
    • Mammalian target of rapamycin complex 1-mediated phosphorylation of eukaryotic initiation factor 4E-binding protein 1 requires multiple protein-protein interactions for substrate recognition
    • Dunlop E.A., Dodd K.M., Seymour L.A., Tee A.R. Mammalian target of rapamycin complex 1-mediated phosphorylation of eukaryotic initiation factor 4E-binding protein 1 requires multiple protein-protein interactions for substrate recognition. Cell Signal 2009, 21:1073-1084.
    • (2009) Cell Signal , vol.21 , pp. 1073-1084
    • Dunlop, E.A.1    Dodd, K.M.2    Seymour, L.A.3    Tee, A.R.4
  • 28
    • 0036181011 scopus 로고    scopus 로고
    • Caspase cleavage of initiation factor 4E-binding protein 1 yields a dominant inhibitor of cap-dependent translation and reveals a novel regulatory motif
    • Tee A.R., Proud C.G. Caspase cleavage of initiation factor 4E-binding protein 1 yields a dominant inhibitor of cap-dependent translation and reveals a novel regulatory motif. Mol Cell Biol 2002, 22:1674-1683.
    • (2002) Mol Cell Biol , vol.22 , pp. 1674-1683
    • Tee, A.R.1    Proud, C.G.2
  • 29
    • 33745263990 scopus 로고    scopus 로고
    • Different roles for the TOS and RAIP motifs of the translational regulator protein 4E-BP1 in the association with raptor and phosphorylation by mTOR in the regulation of cell size
    • Eguchi S., Tokunaga C., Hidayat S., Oshiro N., Yoshino K-I., Kikkawa U., et al. Different roles for the TOS and RAIP motifs of the translational regulator protein 4E-BP1 in the association with raptor and phosphorylation by mTOR in the regulation of cell size. Genes Cells 2006, 11:757-766.
    • (2006) Genes Cells , vol.11 , pp. 757-766
    • Eguchi, S.1    Tokunaga, C.2    Hidayat, S.3    Oshiro, N.4    Yoshino, K.-I.5    Kikkawa, U.6
  • 30
    • 61449235398 scopus 로고    scopus 로고
    • Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy
    • Choo A.Y., Blenis J. Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy. Cell Cycle 2009, 8:567-572.
    • (2009) Cell Cycle , vol.8 , pp. 567-572
    • Choo, A.Y.1    Blenis, J.2
  • 31
    • 0033150672 scopus 로고    scopus 로고
    • Topological characteristics of helical repeat proteins
    • Groves M.R., Barford D. Topological characteristics of helical repeat proteins. Curr Opin Struct Biol 1999, 9:383-389.
    • (1999) Curr Opin Struct Biol , vol.9 , pp. 383-389
    • Groves, M.R.1    Barford, D.2
  • 32
    • 80054736907 scopus 로고    scopus 로고
    • Structural basis for activation and inhibition of class I phosphoinositide 3-kinases
    • Vadas O., Burke J.E., Zhang X., Berndt A., Williams R.L. Structural basis for activation and inhibition of class I phosphoinositide 3-kinases. Sci Signal 2011, 4:re2-re12.
    • (2011) Sci Signal , vol.4 , pp. re2-re12
    • Vadas, O.1    Burke, J.E.2    Zhang, X.3    Berndt, A.4    Williams, R.L.5
  • 34
    • 33847651745 scopus 로고    scopus 로고
    • Point mutations in TOR confer Rheb-independent growth in fission yeast and nutrient-independent mammalian TOR signaling in mammalian cells
    • Urano J., Sato T., Matsuo T., Otsubo Y., Yamamoto M., Tamanoi F. Point mutations in TOR confer Rheb-independent growth in fission yeast and nutrient-independent mammalian TOR signaling in mammalian cells. Proc Natl Acad Sci USA 2007, 104:3514-3519.
    • (2007) Proc Natl Acad Sci USA , vol.104 , pp. 3514-3519
    • Urano, J.1    Sato, T.2    Matsuo, T.3    Otsubo, Y.4    Yamamoto, M.5    Tamanoi, F.6
  • 35
    • 33846024055 scopus 로고    scopus 로고
    • Caffeine targets TOR complex I and provides evidence for a regulatory link between the FRB and kinase domains of Tor1p
    • Reinke A., Chen J.C., Aronova S., Powers T. Caffeine targets TOR complex I and provides evidence for a regulatory link between the FRB and kinase domains of Tor1p. J Biol Chem 2006, 281:31616-31626.
    • (2006) J Biol Chem , vol.281 , pp. 31616-31626
    • Reinke, A.1    Chen, J.C.2    Aronova, S.3    Powers, T.4
  • 36
    • 77952243626 scopus 로고    scopus 로고
    • Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer
    • Sato T., Nakashima A., Guo L., Coffman K., Tamanoi F. Single amino-acid changes that confer constitutive activation of mTOR are discovered in human cancer. Oncogene 2010, 29:2746-2752.
    • (2010) Oncogene , vol.29 , pp. 2746-2752
    • Sato, T.1    Nakashima, A.2    Guo, L.3    Coffman, K.4    Tamanoi, F.5
  • 37
    • 84899680978 scopus 로고    scopus 로고
    • Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib
    • Wagle N., Grabiner B.C., Van Allen E.M., Hodis E., Jacobus S., Supko J.G., et al. Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib. Cancer Discov 2014, 4:546-553.
    • (2014) Cancer Discov , vol.4 , pp. 546-553
    • Wagle, N.1    Grabiner, B.C.2    Van Allen, E.M.3    Hodis, E.4    Jacobus, S.5    Supko, J.G.6
  • 39
    • 84899678098 scopus 로고    scopus 로고
    • A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity
    • Grabiner B.C., Nardi V., Birsoy K., Possemato R., Shen K., Sinha S., et al. A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity. Cancer Discov 2014, 4:554-563.
    • (2014) Cancer Discov , vol.4 , pp. 554-563
    • Grabiner, B.C.1    Nardi, V.2    Birsoy, K.3    Possemato, R.4    Shen, K.5    Sinha, S.6
  • 40
    • 79953308071 scopus 로고    scopus 로고
    • Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms
    • Jura N., Zhang X., Endres N.F., Seeliger M.A., Schindler T., Kuriyan J. Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms. Mol Cell 2011, 42:9-22.
    • (2011) Mol Cell , vol.42 , pp. 9-22
    • Jura, N.1    Zhang, X.2    Endres, N.F.3    Seeliger, M.A.4    Schindler, T.5    Kuriyan, J.6
  • 41
    • 0028773477 scopus 로고
    • Three protein kinase structures define a common motif
    • Taylor S.S., Radzio-Andzelm E. Three protein kinase structures define a common motif. Structure 1994, 2:345-355.
    • (1994) Structure , vol.2 , pp. 345-355
    • Taylor, S.S.1    Radzio-Andzelm, E.2
  • 42
    • 79551594605 scopus 로고    scopus 로고
    • Protein kinases: evolution of dynamic regulatory proteins
    • Taylor S.S., Kornev A.P. Protein kinases: evolution of dynamic regulatory proteins. Trends Biochem Sci 2011, 36:65-77.
    • (2011) Trends Biochem Sci , vol.36 , pp. 65-77
    • Taylor, S.S.1    Kornev, A.P.2
  • 43
    • 0029029617 scopus 로고
    • Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex
    • Jeffrey P.D., Russo A.A., Polyak K., Gibbs E., Hurwitz J., Massagué J., et al. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 1995, 376:313-320.
    • (1995) Nature , vol.376 , pp. 313-320
    • Jeffrey, P.D.1    Russo, A.A.2    Polyak, K.3    Gibbs, E.4    Hurwitz, J.5    Massagué, J.6
  • 44
    • 0029831167 scopus 로고    scopus 로고
    • Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002
    • Brunn G.J., Williams J., Sabers C., Wiederrecht G., Lawrence J.J., Abraham R.T. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. Embo J 1996, 15:5256-5267.
    • (1996) Embo J , vol.15 , pp. 5256-5267
    • Brunn, G.J.1    Williams, J.2    Sabers, C.3    Wiederrecht, G.4    Lawrence, J.J.5    Abraham, R.T.6
  • 45
    • 0029965452 scopus 로고    scopus 로고
    • Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction
    • Wymann M.P., Bulgarelli-Leva G., Zvelebil M.J., Pirola L., Vanhaesebroeck B., Waterfield M.D., et al. Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol Cell Biol 1996, 16:1722-1733.
    • (1996) Mol Cell Biol , vol.16 , pp. 1722-1733
    • Wymann, M.P.1    Bulgarelli-Leva, G.2    Zvelebil, M.J.3    Pirola, L.4    Vanhaesebroeck, B.5    Waterfield, M.D.6
  • 46
    • 0033634827 scopus 로고    scopus 로고
    • Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine
    • Walker E.H., Pacold M.E., Perisic O., Stephens L., Hawkins P.T., Wymann M.P., et al. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 2000, 6:909-919.
    • (2000) Mol Cell , vol.6 , pp. 909-919
    • Walker, E.H.1    Pacold, M.E.2    Perisic, O.3    Stephens, L.4    Hawkins, P.T.5    Wymann, M.P.6
  • 47
    • 0025330489 scopus 로고
    • CAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes
    • Taylor S.S., Buechler J.A., Yonemoto W. cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu Rev Biochem 1990, 59:971-1005.
    • (1990) Annu Rev Biochem , vol.59 , pp. 971-1005
    • Taylor, S.S.1    Buechler, J.A.2    Yonemoto, W.3
  • 49
    • 0035413606 scopus 로고    scopus 로고
    • Kinetic and catalytic mechanisms of protein kinases
    • Adams J.A. Kinetic and catalytic mechanisms of protein kinases. Chem Rev 2001, 101:2271-2290.
    • (2001) Chem Rev , vol.101 , pp. 2271-2290
    • Adams, J.A.1
  • 50
    • 79958696694 scopus 로고    scopus 로고
    • The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling
    • Hsu P.P., Kang S.A., Rameseder J., Zhang Y., Ottina K.A., Lim D., et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 2011, 332:1317-1322.
    • (2011) Science , vol.332 , pp. 1317-1322
    • Hsu, P.P.1    Kang, S.A.2    Rameseder, J.3    Zhang, Y.4    Ottina, K.A.5    Lim, D.6
  • 51
    • 0033581886 scopus 로고    scopus 로고
    • Structural insights into phosphoinositide 3-kinase catalysis and signalling
    • Walker E.H., Perisic O., Ried C., Stephens L., Williams R.L. Structural insights into phosphoinositide 3-kinase catalysis and signalling. Nature 1999, 402:313-320.
    • (1999) Nature , vol.402 , pp. 313-320
    • Walker, E.H.1    Perisic, O.2    Ried, C.3    Stephens, L.4    Williams, R.L.5
  • 52
    • 77950212231 scopus 로고    scopus 로고
    • Shaping development of autophagy inhibitors with the structure of the lipid kinase Vps34
    • Miller S., Tavshanjian B., Oleksy A., Perisic O., Houseman B.T., Shokat K.M., et al. Shaping development of autophagy inhibitors with the structure of the lipid kinase Vps34. Science 2010, 327:1638-1642.
    • (2010) Science , vol.327 , pp. 1638-1642
    • Miller, S.1    Tavshanjian, B.2    Oleksy, A.3    Perisic, O.4    Houseman, B.T.5    Shokat, K.M.6
  • 53
    • 79951993684 scopus 로고    scopus 로고
    • Structure of lipid kinase p110beta/p85beta elucidates an unusual SH2-domain-mediated inhibitory mechanism
    • Zhang X., Vadas O., Perisic O., Anderson K.E., Clark J., Hawkins P.T., et al. Structure of lipid kinase p110beta/p85beta elucidates an unusual SH2-domain-mediated inhibitory mechanism. Mol Cell 2011, 41:567-578.
    • (2011) Mol Cell , vol.41 , pp. 567-578
    • Zhang, X.1    Vadas, O.2    Perisic, O.3    Anderson, K.E.4    Clark, J.5    Hawkins, P.T.6
  • 54
    • 0034234924 scopus 로고    scopus 로고
    • A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells
    • Sekulic A., Hudson C.C., Homme J.L., Yin P., Otterness D.M., Karnitz L.M., et al. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res 2000, 60:3504-3513.
    • (2000) Cancer Res , vol.60 , pp. 3504-3513
    • Sekulic, A.1    Hudson, C.C.2    Homme, J.L.3    Yin, P.4    Otterness, D.M.5    Karnitz, L.M.6
  • 55
    • 0036837863 scopus 로고    scopus 로고
    • The rapamycin-binding domain governs substrate selectivity by the mammalian target of rapamycin
    • McMahon L.P., Choi K.M., Lin T.A., Abraham R.T., Lawrence J.J. The rapamycin-binding domain governs substrate selectivity by the mammalian target of rapamycin. Mol Cell Biol 2002, 22:7428-7438.
    • (2002) Mol Cell Biol , vol.22 , pp. 7428-7438
    • McMahon, L.P.1    Choi, K.M.2    Lin, T.A.3    Abraham, R.T.4    Lawrence, J.J.5
  • 56
    • 3342931591 scopus 로고    scopus 로고
    • An activated mTOR mutant supports growth factor-independent, nutrient-dependent cell survival
    • Edinger A.L., Thompson C.B. An activated mTOR mutant supports growth factor-independent, nutrient-dependent cell survival. Oncogene 2004, 23:5654-5663.
    • (2004) Oncogene , vol.23 , pp. 5654-5663
    • Edinger, A.L.1    Thompson, C.B.2
  • 58
    • 55749102720 scopus 로고    scopus 로고
    • A helix scaffold for the assembly of active protein kinases
    • Kornev A.P., Taylor S.S., Eyck Ten L.F. A helix scaffold for the assembly of active protein kinases. Proc Natl Acad Sci USA 2008, 105:14377-14382.
    • (2008) Proc Natl Acad Sci USA , vol.105 , pp. 14377-14382
    • Kornev, A.P.1    Taylor, S.S.2    Eyck Ten, L.F.3
  • 60
    • 0029842109 scopus 로고    scopus 로고
    • Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP
    • Choi J., Chen J., Schreiber S.L., Clardy J. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP. Science 1996, 273:239-242.
    • (1996) Science , vol.273 , pp. 239-242
    • Choi, J.1    Chen, J.2    Schreiber, S.L.3    Clardy, J.4
  • 61
    • 16844385435 scopus 로고    scopus 로고
    • Characterization of the FKBP.rapamycin.FRB ternary complex
    • Banaszynski L.A., Liu C.W., Wandless T.J. Characterization of the FKBP.rapamycin.FRB ternary complex. J Am Chem Soc 2005, 127:4715-4721.
    • (2005) J Am Chem Soc , vol.127 , pp. 4715-4721
    • Banaszynski, L.A.1    Liu, C.W.2    Wandless, T.J.3
  • 62
    • 79953298958 scopus 로고    scopus 로고
    • Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy
    • Wander S.A., Hennessy B.T., Slingerland J.M. Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy. J Clin Invest 2011, 121:1231-1241.
    • (2011) J Clin Invest , vol.121 , pp. 1231-1241
    • Wander, S.A.1    Hennessy, B.T.2    Slingerland, J.M.3
  • 63
    • 61349141302 scopus 로고    scopus 로고
    • Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2
    • Feldman M.E., Apsel B., Uotila A., Loewith R., Knight Z.A., Ruggero D., et al. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol 2009, 7:e38.
    • (2009) PLoS Biol , vol.7 , pp. e38
    • Feldman, M.E.1    Apsel, B.2    Uotila, A.3    Loewith, R.4    Knight, Z.A.5    Ruggero, D.6
  • 64
    • 79952265072 scopus 로고    scopus 로고
    • Discovery of 9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a potent, selective, and orally available mammalian target of rapamycin (mTOR) inhibitor for treatment of cancer
    • Liu Q., Wang J., Kang S.A., Thoreen C.C., Hur W., Ahmed T., et al. Discovery of 9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a potent, selective, and orally available mammalian target of rapamycin (mTOR) inhibitor for treatment of cancer. J Med Chem 2011, 54:1473-1480.
    • (2011) J Med Chem , vol.54 , pp. 1473-1480
    • Liu, Q.1    Wang, J.2    Kang, S.A.3    Thoreen, C.C.4    Hur, W.5    Ahmed, T.6
  • 66
    • 84894114029 scopus 로고    scopus 로고
    • Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome
    • Menon S., Dibble C.C., Talbott G., Hoxhaj G., Valvezan A.J., Takahashi H., et al. Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell 2014, 156:771-785.
    • (2014) Cell , vol.156 , pp. 771-785
    • Menon, S.1    Dibble, C.C.2    Talbott, G.3    Hoxhaj, G.4    Valvezan, A.J.5    Takahashi, H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.